Webbläsaren som du använder stöds inte av denna webbplats. Alla versioner av Internet Explorer stöds inte längre, av oss eller Microsoft (läs mer här: * https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Var god och använd en modern webbläsare för att ta del av denna webbplats, som t.ex. nyaste versioner av Edge, Chrome, Firefox eller Safari osv.

miR-126 Regulates Distinct Self-Renewal Outcomes in Normal and Malignant Hematopoietic Stem Cells.

Författare

  • Eric R Lechman
  • Bernhard Gentner
  • Stanley W K Ng
  • Erwin M Schoof
  • Peter van Galen
  • James A Kennedy
  • Silvia Nucera
  • Fabio Ciceri
  • Kerstin B Kaufmann
  • Naoya Takayama
  • Stephanie M Dobson
  • Aaron Trotman-Grant
  • Gabriela Krivdova
  • Janneke Elzinga
  • Amanda Mitchell
  • Björn Nilsson
  • Karin G Hermans
  • Kolja Eppert
  • Rene Marke
  • Ruth Isserlin
  • Veronique Voisin
  • Gary D Bader
  • Peter W Zandstra
  • Todd R Golub
  • Benjamin L Ebert
  • Jun Lu
  • Mark Minden
  • Jean C Y Wang
  • Luigi Naldini
  • John E Dick

Summary, in English

To investigate miRNA function in human acute myeloid leukemia (AML) stem cells (LSC), we generated a prognostic LSC-associated miRNA signature derived from functionally validated subpopulations of AML samples. For one signature miRNA, miR-126, high bioactivity aggregated all in vivo patient sample LSC activity into a single sorted population, tightly coupling miR-126 expression to LSC function. Through functional studies, miR-126 was found to restrain cell cycle progression, prevent differentiation, and increase self-renewal of primary LSC in vivo. Compared with prior results showing miR-126 regulation of normal hematopoietic stem cell (HSC) cycling, these functional stem effects are opposite between LSC and HSC. Combined transcriptome and proteome analysis demonstrates that miR-126 targets the PI3K/AKT/MTOR signaling pathway, preserving LSC quiescence and promoting chemotherapy resistance.

Avdelning/ar

Publiceringsår

2016

Språk

Engelska

Sidor

214-228

Publikation/Tidskrift/Serie

Cancer Cell

Volym

29

Issue

2

Dokumenttyp

Artikel i tidskrift

Förlag

Cell Press

Ämne

  • Cancer and Oncology

Status

Published

ISBN/ISSN/Övrigt

  • ISSN: 1878-3686